Yosafe Wakwaya, M.D.

NPI 1205275336ActiveIndividual· Internal Medicine, Pulmonary Disease· Dallas, TX

Internal Medicine, Pulmonary Disease (M.D.) in Dallas, Texas, trained at University of Missouri, Kansas City, School of Medicine (class of 2013). Their prescriptions cost Medicare Part D more than their services did: $2,656,160 for 1,150 claims, against $41,596 paid for services in 2024. Glaxosmithkline, LLC. was the largest of 14 companies reporting payments in 2025, $1,564 in all, mostly food and beverage.

Overview

NPI	1205275336
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jun 21, 2013
Last updated in NPPES	May 13, 2021
Certified by provider	May 13, 2021

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	S8671	TX
Internal Medicine	207R00000X	58748	CO

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	199
Services billed	659 across 21 procedure codes
Paid by Medicare	$41,596

Part D prescriptions in 2024

Prescriptions (claims)	1,150 · 1,621 30-day fills
Patients	162
Total drug cost	$2,656,160
Generic share	47% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Missouri, Kansas City, School of Medicine
Graduation year	2013
Medicare specialty	Pulmonary Disease
Secondary specialties	Critical Care (Intensivists), Internal Medicine